
CAS 1092578-46-5
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
9 Produkte.
3-((3R,4S)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
CAS:Formel:C16H20N6OReinheit:98%Farbe und Form:SolidMolekulargewicht:312.3696Tofacitinib Impurity 42
CAS:Formel:C16H20N6OFarbe und Form:White To Off-White SolidMolekulargewicht:312.383-((3R,4S)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
CAS:3-((3R,4S)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrileReinheit:98%Molekulargewicht:312.38g/mol(3R,4S)-Tofacitinib
CAS:Kontrolliertes Produkt<p>Applications (3R,4S)-Tofacitinib is an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.<br>References Jiang, J., et. al.: J. med. Chem., 51, 8012 (2008)<br></p>Formel:C16H20N6OFarbe und Form:NeatMolekulargewicht:312.37(3R,4S)-Tofacitinib-d3
CAS:Kontrolliertes ProduktFormel:C16D3H17N6OFarbe und Form:NeatMolekulargewicht:315.388(3R,4S)-Tofacitinib
CAS:<p>(3R,4S)-Tofacitinib is a synthetic compound that is being researched for the treatment of rheumatoid arthritis. It is a potent inhibitor of Janus Kinase 3 (JAK3) and Janus Kinase 1 (JAK1), which are important enzymes in cytokine signaling pathways that play a role in inflammation. (3R,4S)-Tofacitinib is metabolized to an impurity standard for the drug product. The metabolite has not been characterized and its concentration cannot be determined from analytical data.</p>Formel:C16H20N6OReinheit:Min. 95%Molekulargewicht:312.37 g/mol(3R,4S)-Tofacitinib
CAS:(3R,4S)-Tofacitinib, the less active enantiomer of Tofacitinib, is a JAK3 inhibitor with an IC50 of 1 nM.Formel:C16H20N6OReinheit:98%Farbe und Form:SolidMolekulargewicht:312.37






